Prostate Delineation: High Quality Volume CT
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01878773|
Recruitment Status : Completed
First Posted : June 17, 2013
Last Update Posted : August 22, 2017
This study will look at how feasible it is to use a certain type of Computed Tomography (CT) to scan prostate cancer, called a high quality volume CT scan. It is hoped that this technique will help doctors provide a higher-quality image of the prostate cancer, making it easier to plan the area that will be treated. Using this type of CT scan will also lessen the amount of time patients spend in the scanner.
This study will not offer patients a different treatment for their prostate cancer. Patients will receive the most appropriate standard treatment whether or not they are in this study.
|Condition or disease||Intervention/treatment||Phase|
|Prostate Cancer||Other: High Quality Volume CT Scan; MRI Scan||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Prostate Delineation During Radiation Treatment Planning for Prostate Cancer: Comparison of High Quality Volume Computerized Tomography With Conventional Tomography and Magnetic Resonance Imaging|
|Study Start Date :||October 2012|
|Actual Primary Completion Date :||August 11, 2017|
|Actual Study Completion Date :||August 11, 2017|
High Quality Volume CT Scan; MRI Scan
Patients will have the High Quality volume CT scan immediately after their CT scan followed by MRI Scan.
Other: High Quality Volume CT Scan; MRI Scan
Patients will have the High Quality volume CT scan immediately after their CT scan followed by MRI scan.
- Using different scanning methods for patients undergoing radical external beam radiotherapy for prostate cancer to determine inter-observer variability in prostate gland delineation on the images. [ Time Frame: 6 months ]
- Determine the concordance between delineators in identifying the prostate apex on the 2 CT image sets. MRI will be considered the "gold-standard" for identifying the prostate apex. [ Time Frame: 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01878773
|University Health Network, The Princess Margaret|
|Toronto, Ontario, Canada, M5G 2M9|